Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.

Di Popolo A, Memoli A, Apicella A, Tuccillo C, di Palma A, Ricchi P, Acquaviva AM, Zarrilli R.

Oncogene. 2000 Nov 16;19(48):5517-24.

2.
3.

Elevated ceramide is downstream of altered calcium homeostasis in low serum-induced apoptosis.

Jayadev S, Barrett JC, Murphy E.

Am J Physiol Cell Physiol. 2000 Nov;279(5):C1640-7.

4.

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy.

Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T.

J Cell Biol. 2000 Oct 2;151(1):117-30.

5.

Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis.

Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, Nakatani Y.

Cell. 2000 Aug 18;102(4):463-73.

6.

Acetylation of histones and transcription-related factors.

Sterner DE, Berger SL.

Microbiol Mol Biol Rev. 2000 Jun;64(2):435-59. Review.

8.

Tip60 is a nuclear hormone receptor coactivator.

Brady ME, Ozanne DM, Gaughan L, Waite I, Cook S, Neal DE, Robson CN.

J Biol Chem. 1999 Jun 18;274(25):17599-604.

9.

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.

Dechend R, Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn FG, Scheidereit C, Leutz A.

Oncogene. 1999 Jun 3;18(22):3316-23.

10.

Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression.

Benoit H, Jordan M, Wagner H, Wagner PD.

J Appl Physiol (1985). 1999 May;86(5):1513-8.

11.

Reduced capacitative calcium entry correlates with vesicle accumulation and apoptosis.

Jayadev S, Petranka JG, Cheran SK, Biermann JA, Barrett JC, Murphy E.

J Biol Chem. 1999 Mar 19;274(12):8261-8.

12.

VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling.

Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, Hebbel RP.

Exp Cell Res. 1999 Mar 15;247(2):495-504.

PMID:
10066377
13.

Suppression or elevation of cytosolic phospholipase A2 alters keratinocyte prostaglandin synthesis, growth, and apoptosis.

Lo HH, Teichmann P, F├╝rstenberger G, Gimenez-Conti I, Fischer SM.

Cancer Res. 1998 Oct 15;58(20):4624-31.

14.

Regulation of survival and death of mesangial cells by extracellular matrix.

Sugiyama H, Kashihara N, Maeshima Y, Okamoto K, Kanao K, Sekikawa T, Makino H.

Kidney Int. 1998 Oct;54(4):1188-96.

15.

Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells.

Wu YL, Jiang XR, Newland AC, Kelsey SM.

J Immunol. 1998 Jun 15;160(12):5929-35.

16.
17.

Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy.

Spencer AG, Woods JW, Arakawa T, Singer II, Smith WL.

J Biol Chem. 1998 Apr 17;273(16):9886-93.

18.

ESA1 is a histone acetyltransferase that is essential for growth in yeast.

Smith ER, Eisen A, Gu W, Sattah M, Pannuti A, Zhou J, Cook RG, Lucchesi JC, Allis CD.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3561-5.

19.

Supplemental Content

Support Center